BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 88538)

  • 21. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
    Ziai MR; Imberti L; Tongson A; Ferrone S
    Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated antigens in human malignant melanoma.
    Lewis MG; Avis PJ; Phillips TM; Sheikh KM
    Yale J Biol Med; 1973 Dec; 46(5):661-8. PubMed ID: 4591789
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
    Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
    Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of immunogenic human melanoma antigens in a polyvalent melanoma vaccine.
    Bystryn JC; Henn M; Li J; Shroba S
    Cancer Res; 1992 Nov; 52(21):5948-53. PubMed ID: 1382848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solubilization and partial isolation of human melanoma tumor-associated antigens.
    Stuhlmiller GM; Green RW; Seigler HF
    J Natl Cancer Inst; 1978 Jul; 61(1):61-7. PubMed ID: 276639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of a melanoma tumor-associated antigen detected in the spent culture medium of a human melanoma cell line by allogeneic antibody. II. Immunobiologic characterization.
    Gupta RK; Morton DL
    J Natl Cancer Inst; 1984 Jan; 72(1):75-82. PubMed ID: 6582305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunologic reaction-readiness in malignant melanoma].
    Bickhardt R; Kunze J
    Z Hautkr; 1974 Apr; 49(8):315-33. PubMed ID: 4599330
    [No Abstract]   [Full Text] [Related]  

  • 28. Indirect rosette microassay to characterize human melanoma-associated antigens recognized by operationally specific xenoantisera.
    Imai K; Ferrone S
    Cancer Res; 1980 Jul; 40(7):2252-6. PubMed ID: 6966965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterotransplantation model of human malignant melanoma.
    Mukherji B; Flowers A; Nathanson L; Clark DA
    Cancer Res; 1974 Jan; 34(1):43-6. PubMed ID: 4588548
    [No Abstract]   [Full Text] [Related]  

  • 30. Antibody-induced movement of common melanoma membrane antigens on the surface of unfixed human melanoma cells.
    Leong SP; Cooperband SR; Deckers PJ; Sutherland CM; Cesare JF; Krementz ET
    Cancer Res; 1979 Jun; 39(6 Pt 1):2125-31. PubMed ID: 376115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and purification of a Mr 75,000 cell surface human melanoma-associated antigen.
    Heaney-Kieras J; Bystryn JC
    Cancer Res; 1982 Jun; 42(6):2310-6. PubMed ID: 7042082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human monoclonal antibody to tumor-associated ganglioside GD2.
    Katano M; Saxton RE; Irie RF
    J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response and tumor growth in syngeneic mice immunized to partially purified B16 melanoma-associated antigens.
    Bystryn JC
    J Immunol; 1978 Jan; 120(1):96-101. PubMed ID: 627729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common human melanoma-associated antigen(s) detected by monoclonal antibodies.
    Carrel S; Accolla RS; Carmagnola AL; Mach JP
    Cancer Res; 1980 Jul; 40(7):2523-8. PubMed ID: 6155995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degradation of tumor-associated antigens shed by human melanoma cells in culture.
    Boctor AM; Bystryn JC
    Cancer Res; 1982 Jun; 42(6):2121-5. PubMed ID: 7074593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
    Alexander MA; Bennicelli J; Guerry D
    J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
    Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
    Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor-associated antigens in spent medium of human melanoma cells: immunochemical characterization with xenoantisera.
    Galloway DR; McCabe RP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1981 Jan; 126(1):62-6. PubMed ID: 7451981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
    Leong SP; Sutherland CM; Krementz ET
    Cancer Res; 1977 Nov; 37(11):4035-42. PubMed ID: 332343
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current status of monoclonal antibodies to human melanoma and its application].
    Imai K; Adachi M; Yachi A
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):852-60. PubMed ID: 6192770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.